Deborah Wenkert
2021
In 2021, Deborah Wenkert earned a total compensation of $2.4M as Former Senior Vice President and Former Chief Medical Officer at Inozyme Pharma.
Compensation breakdown
| Option Awards | $1,891,259 |
|---|---|
| Salary | $361,106 |
| Other | $109,918 |
| Total | $2,362,283 |
Wenkert received $1.9M in option awards, accounting for 80% of the total pay in 2021.
Wenkert also received $361.1K in salary and $109.9K in other compensation.
Rankings
In 2021, Deborah Wenkert's compensation ranked 5,387th out of 12,415 executives tracked by ExecPay. In other words, Wenkert earned more than 56.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,387 out of 12,415 | 57th |
Division Manufacturing | 2,270 out of 5,505 | 59th |
Major group Chemicals And Allied Products | 988 out of 2,375 | 58th |
Industry group Drugs | 880 out of 2,096 | 58th |
Industry Pharmaceutical Preparations | 631 out of 1,546 | 59th |
Source: SEC filing on April 27, 2022.
Wenkert's colleagues
We found three more compensation records of executives who worked with Deborah Wenkert at Inozyme Pharma in 2021.